Oral and intravenous carbohydrate challenges decrease active ghrelin concentrations and alter hormones related to control of energy metabolism in horses.
This study tested the hypothesis that grain and intravenous dextrose challenges would alter plasma concentrations of active ghrelin, adiponectin, leptin, glucose, insulin, and cortisol in Standardbred mares. To deliver 0.5 g of glucose (dextrose solution for the intravenous test)/kg of BW, mares received intravenous dextrose (50% solution) or oral grain administration in 2 trials. In response to the oral grain challenge, plasma glucose and insulin concentrations increased (P < 0.001) by 56 and 802%, respectively. Plasma ghrelin concentration initially decreased (P < 0.001) by 40%, then subsequently increased (P < 0.05) from its nadir by 259%. Plasma leptin concentration decreased (P = 0.002) 17% compared with baseline. There was no change (P = 0.34) in plasma adiponectin concentration in response to oral grain challenge; however, plasma cortisol concentrations decreased (P < 0.001) by 24%. In response to the intravenous dextrose challenge, plasma glucose and insulin concentrations increased (P < 0.001) by 432 and 395%, respectively. Plasma active ghrelin concentration initially decreased (P < 0.001) by 56%, then subsequently increased (P < 0.001) from its nadir by 314%. Plasma leptin concentration also increased (P < 0.001) by 33% compared with baseline. There was no change (P = 0.18) in plasma adiponectin concentration throughout the dextrose challenge. Plasma cortisol concentration increased (P = 0.027) by 20%. Hence, oral grain and intravenous nutrient challenges have the ability to alter variables potentially related to energy metabolism in mares, with acute changes in glucose and insulin possibly modulating changes in ghrelin and leptin.
Gordon
M E
ME
Equine Science Center, Department of Animal Sciences, Rutgers, the State University of New Jersey, 84 Lipman Drive, New Brunswick 08901, USA.
McKeever
K H
KH
D052242:Adiponectin / Q000097:blood; D000284:Administration, Oral; D000821:Animal Feed; D000818:Animals; D001786:Blood Glucose; D004040:Dietary Carbohydrates / Q000008:administration & dosage* / Q000494:pharmacology*; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D054439:Ghrelin; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology; D006736:Horses / Q000378:metabolism*; D006854:Hydrocortisone / Q000097:blood; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D020738:Leptin / Q000097:blood; D036361:Peptide Hormones / Q000378:metabolism*
D052242:Adiponectin; D001786:Blood Glucose; D004040:Dietary Carbohydrates; D054439:Ghrelin; D007328:Insulin; D020738:Leptin; D036361:Peptide Hormones; D005947:Glucose; D006854:Hydrocortisone